Skip to main content
Erschienen in: Surgical Endoscopy 4/2020

18.06.2019 | 2019 SAGES Oral

Surgeon variation in severity of reflux symptoms after sleeve gastrectomy

verfasst von: Oliver A. Varban, Jyothi R. Thumma, Dana A. Telem, Nabeel R. Obeid, Jonathan F. Finks, Amir A. Ghaferi, Justin B. Dimick

Erschienen in: Surgical Endoscopy | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Prior studies have demonstrated an increase in gastroesophageal reflux after laparoscopic sleeve gastrectomy (LSG). However, it is unknown whether symptom severity varies or if outcomes are surgeon-specific.

Methods

A validated reflux symptom survey was obtained at baseline and at 1 year after primary LSG on 7358 patients participating in a state-wide quality improvement collaborative between 2013 and 2018. Patients with worsening symptoms after surgery were divided into terciles based on the degree of increase in survey score (0 = no symptoms, 50 = max symptoms). Surgeon-level data was obtained on 52 bariatric surgeons performing at least 25 LSG cases/year during the study period. Surgeon characteristics, operative experience, and risk-adjusted 30-day complication rates were compared between surgeons in the highest tercile for moderate worsening of symptoms vs those in the lowest.

Results

A total of 2294 (31.2%) patients had worsening symptoms of reflux after sleeve gastrectomy. Overall mean increase in severity score was 6.11 (range 1 to 48) and patients with minimal, mild, and moderate symptoms had a mean increase of 1.4, 4.2, and 13.8, respectively. There were no significant differences in surgeon-specific characteristics when comparing surgeons in the highest tercile for moderate worsening of symptoms (44.7% of patients) vs those in the lowest tercile (18.7% of patients). In addition, there were no significant differences in risk-adjusted rates of overall complications (3.70% vs. 4.33%, p = 0.686), endoscopic dilations (2.83% vs. 1.91%, p = 0.417), or concurrent hiatal hernia repair (34.3% vs. 27.0%, p = 0.415) between surgeons in the highest and lowest terciles.

Conclusions

We found that 1/3 of patients had worsening symptoms of reflux after LSG and that severity of symptoms varied. Surgeons with the highest rates of worsening reflux had similar operative experience and complication rates than those with the lowest. Further assessment of operative technique and skill may be informative.
Literatur
1.
Zurück zum Zitat English WJ, DeMaria EJ, Brethauer SA, Mattar SG, Rosenthal RJ, Morton JM (2018) American society for metabolic and bariatric surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis 14:259–263CrossRefPubMed English WJ, DeMaria EJ, Brethauer SA, Mattar SG, Rosenthal RJ, Morton JM (2018) American society for metabolic and bariatric surgery estimation of metabolic and bariatric procedures performed in the United States in 2016. Surg Obes Relat Dis 14:259–263CrossRefPubMed
2.
Zurück zum Zitat Borbély Y, Schaffner E, Zimmermann L, Huguenin M, Plitzko G, Nett P, Kröll D (2019) De novo gastroesophageal reflux disease after sleeve gastrectomy: role of preoperative silent reflux. Surg Endosc 33:789–793CrossRefPubMed Borbély Y, Schaffner E, Zimmermann L, Huguenin M, Plitzko G, Nett P, Kröll D (2019) De novo gastroesophageal reflux disease after sleeve gastrectomy: role of preoperative silent reflux. Surg Endosc 33:789–793CrossRefPubMed
3.
Zurück zum Zitat Burgerhart JS, Schotborgh CAI, Schoon EJ, Smulders JF, van de Meeberg PC, Siersema PD, Smout AJPM (2014) Effect of sleeve gastrectomy on gastroesophageal reflux. Obes Surg 24:1436–1441CrossRefPubMed Burgerhart JS, Schotborgh CAI, Schoon EJ, Smulders JF, van de Meeberg PC, Siersema PD, Smout AJPM (2014) Effect of sleeve gastrectomy on gastroesophageal reflux. Obes Surg 24:1436–1441CrossRefPubMed
4.
5.
Zurück zum Zitat Gorodner V, Buxhoeveden R, Clemente G, Solé L, Caro L, Grigaites A (2015) Does laparoscopic sleeve gastrectomy have any influence on gastroesophageal reflux disease? Preliminary results. Surg Endosc 29:1760–1768CrossRefPubMed Gorodner V, Buxhoeveden R, Clemente G, Solé L, Caro L, Grigaites A (2015) Does laparoscopic sleeve gastrectomy have any influence on gastroesophageal reflux disease? Preliminary results. Surg Endosc 29:1760–1768CrossRefPubMed
6.
Zurück zum Zitat Laffin M, Chau J, Gill RS, Birch DW, Karmali S (2013) Sleeve gastrectomy and gastroesophageal reflux disease. J Obes 2013:1–6CrossRef Laffin M, Chau J, Gill RS, Birch DW, Karmali S (2013) Sleeve gastrectomy and gastroesophageal reflux disease. J Obes 2013:1–6CrossRef
7.
Zurück zum Zitat Melissas J, Braghetto I, Molina JC, Silecchia G, Iossa A, Iannelli A, Foletto M (2015) Gastroesophageal reflux disease and sleeve gastrectomy. Obes Surg 25:2430–2435CrossRefPubMed Melissas J, Braghetto I, Molina JC, Silecchia G, Iossa A, Iannelli A, Foletto M (2015) Gastroesophageal reflux disease and sleeve gastrectomy. Obes Surg 25:2430–2435CrossRefPubMed
8.
Zurück zum Zitat Varban OA, Hawasli AA, Carlin AM, Genaw JA, English W, Dimick JB, Wood MH, Birkmeyer JD, Birkmeyer NJO, Finks JF (2015) Variation in utilization of acid-reducing medication at 1 year following bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Surg Obes Relat Dis 11:222–228CrossRefPubMed Varban OA, Hawasli AA, Carlin AM, Genaw JA, English W, Dimick JB, Wood MH, Birkmeyer JD, Birkmeyer NJO, Finks JF (2015) Variation in utilization of acid-reducing medication at 1 year following bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Surg Obes Relat Dis 11:222–228CrossRefPubMed
9.
Zurück zum Zitat Kleidi E, Theodorou D, Albanopoulos K, Menenakos E, Karvelis MA, Papailiou J, Stamou K, Zografos G, Katsaragakis S, Leandros E (2013) The effect of laparoscopic sleeve gastrectomy on the antireflux mechanism: can it be minimized. Surg Endosc 27:4625–4630CrossRefPubMed Kleidi E, Theodorou D, Albanopoulos K, Menenakos E, Karvelis MA, Papailiou J, Stamou K, Zografos G, Katsaragakis S, Leandros E (2013) The effect of laparoscopic sleeve gastrectomy on the antireflux mechanism: can it be minimized. Surg Endosc 27:4625–4630CrossRefPubMed
10.
Zurück zum Zitat Ayazi S, Lipham JC, Hagen JA, Tang AL, Zehetner J, Leers JM, Oezcelik A, Abate E, Banki F, DeMeester SR, DeMeester TR (2009) A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg 13:1422–1429CrossRefPubMed Ayazi S, Lipham JC, Hagen JA, Tang AL, Zehetner J, Leers JM, Oezcelik A, Abate E, Banki F, DeMeester SR, DeMeester TR (2009) A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg 13:1422–1429CrossRefPubMed
11.
Zurück zum Zitat Clark J, DeMeester TR, Johnson LF, Skinner DB (1975) Twenty-four-hour lower esophageal pH monitoring and the lower esophageal sphincter. Surg Forum 26:362–363PubMed Clark J, DeMeester TR, Johnson LF, Skinner DB (1975) Twenty-four-hour lower esophageal pH monitoring and the lower esophageal sphincter. Surg Forum 26:362–363PubMed
12.
Zurück zum Zitat Velanovich V (2007) The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20:130–134CrossRefPubMed Velanovich V (2007) The development of the GERD-HRQL symptom severity instrument. Dis Esophagus 20:130–134CrossRefPubMed
13.
Zurück zum Zitat Dimick JB, Birkmeyer NJ, Finks JF, Share DA, English WJ, Carlin AM, Birkmeyer JD (2014) Composite measures for profiling hospitals on bariatric surgery performance. JAMA Surg 149:10–16CrossRefPubMedPubMedCentral Dimick JB, Birkmeyer NJ, Finks JF, Share DA, English WJ, Carlin AM, Birkmeyer JD (2014) Composite measures for profiling hospitals on bariatric surgery performance. JAMA Surg 149:10–16CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat DuPree CE, Blair K, Steele SR, Martin MJ (2014) Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg 149:328CrossRefPubMed DuPree CE, Blair K, Steele SR, Martin MJ (2014) Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg 149:328CrossRefPubMed
15.
Zurück zum Zitat Yehoshua RT, Eidelman LA, Stein M, Fichman S, Mazor A, Chen J, Bernstine H, Singer P, Dickman R, Beglaibter N, Shikora SA, Rosenthal RJ, Rubin M (2008) Laparoscopic sleeve gastrectomy—volume and pressure assessment. Obes Surg 18:1083–1088CrossRefPubMed Yehoshua RT, Eidelman LA, Stein M, Fichman S, Mazor A, Chen J, Bernstine H, Singer P, Dickman R, Beglaibter N, Shikora SA, Rosenthal RJ, Rubin M (2008) Laparoscopic sleeve gastrectomy—volume and pressure assessment. Obes Surg 18:1083–1088CrossRefPubMed
16.
Zurück zum Zitat Daes J, Jimenez ME, Said N, Daza JC, Dennis R (2012) Laparoscopic sleeve gastrectomy: symptoms of gastroesophageal reflux can be reduced by changes in surgical technique. Obes Surg 22:1874–1879CrossRefPubMedPubMedCentral Daes J, Jimenez ME, Said N, Daza JC, Dennis R (2012) Laparoscopic sleeve gastrectomy: symptoms of gastroesophageal reflux can be reduced by changes in surgical technique. Obes Surg 22:1874–1879CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Docimo S, Rahmana U, Bates A, Talamini M, Pryor A, Spaniolas K (2019) Concomitant hiatal hernia repair is more common in laparoscopic sleeve gastrectomy than during laparoscopic Roux-en-Y Gastric bypass: an analysis of 130,772 cases. Obes Surg 29:744–746CrossRefPubMed Docimo S, Rahmana U, Bates A, Talamini M, Pryor A, Spaniolas K (2019) Concomitant hiatal hernia repair is more common in laparoscopic sleeve gastrectomy than during laparoscopic Roux-en-Y Gastric bypass: an analysis of 130,772 cases. Obes Surg 29:744–746CrossRefPubMed
Metadaten
Titel
Surgeon variation in severity of reflux symptoms after sleeve gastrectomy
verfasst von
Oliver A. Varban
Jyothi R. Thumma
Dana A. Telem
Nabeel R. Obeid
Jonathan F. Finks
Amir A. Ghaferi
Justin B. Dimick
Publikationsdatum
18.06.2019
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 4/2020
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-06928-2

Weitere Artikel der Ausgabe 4/2020

Surgical Endoscopy 4/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.